141 related articles for article (PubMed ID: 10568859)
1. Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective kappa-opioid agonist, in CCI-neuropathic rats.
Walker J; Catheline G; Guilbaud G; Kayser V
Pain; 1999 Dec; 83(3):509-516. PubMed ID: 10568859
[TBL] [Abstract][Full Text] [Related]
2. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
Binder W; Walker JS
Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
[TBL] [Abstract][Full Text] [Related]
3. Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats.
Jolivalt CG; Jiang Y; Freshwater JD; Bartoszyk GD; Calcutt NA
Diabetologia; 2006 Nov; 49(11):2775-85. PubMed ID: 16924480
[TBL] [Abstract][Full Text] [Related]
4. The antinociceptive activity of kappa- but not delta-opioid receptor agonists is maintained in morphine-tolerant neuropathic rats.
Catheline G; Kayser V; Idänpään-Heikkilä JJ; Guilbaud G
Eur J Pharmacol; 1996 Dec; 318(2-3):273-81. PubMed ID: 9016915
[TBL] [Abstract][Full Text] [Related]
5. Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats.
Catheline G; Guilbaud G; Kayser V
Eur J Pharmacol; 1998 Sep; 357(2-3):171-8. PubMed ID: 9797033
[TBL] [Abstract][Full Text] [Related]
6. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
[TBL] [Abstract][Full Text] [Related]
7. Effects of kappa opioids in the inflamed rat colon.
Sengupta JN; Snider A; Su X; Gebhart GF
Pain; 1999 Feb; 79(2-3):175-85. PubMed ID: 10068163
[TBL] [Abstract][Full Text] [Related]
8. The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats.
Martinez V; Christensen D; Kayser V
Pain; 2002 Oct; 99(3):537-545. PubMed ID: 12406530
[TBL] [Abstract][Full Text] [Related]
9. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
[TBL] [Abstract][Full Text] [Related]
10. Effect of prior treatment with ultra-low-dose morphine on opioid- and nerve injury-induced hyperalgesia in rats.
Wala EP; Sloan PA; Holtman JR
J Opioid Manag; 2011; 7(5):377-89. PubMed ID: 22165037
[TBL] [Abstract][Full Text] [Related]
11. Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain.
Erichsen HK; Hao JX; Xu XJ; Blackburn-Munro G
Pain; 2005 Aug; 116(3):347-358. PubMed ID: 15982817
[TBL] [Abstract][Full Text] [Related]
12. Disability of development of tolerance to morphine and U-50,488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice.
Sounvoravong S; Takahashi M; Nakashima MN; Nakashima K
J Pharmacol Sci; 2004 Mar; 94(3):305-12. PubMed ID: 15037816
[TBL] [Abstract][Full Text] [Related]
13. Tolerance develops to the antiallodynic effects of the peripherally acting opioid loperamide hydrochloride in nerve-injured rats.
He SQ; Yang F; Perez FM; Xu Q; Shechter R; Cheong YK; Carteret AF; Dong X; Sweitzer SM; Raja SN; Guan Y
Pain; 2013 Nov; 154(11):2477-2486. PubMed ID: 23880055
[TBL] [Abstract][Full Text] [Related]
14. Effects of the peripherally selective kappa-opioid asimadoline, on substance P and CGRP mRNA expression in chronic arthritis of the rat.
Walker JS; Scott C; Bush KA; Kirkham BW
Neuropeptides; 2000; 34(3-4):193-202. PubMed ID: 11021980
[TBL] [Abstract][Full Text] [Related]
15. Cross-tolerance to acute administration of mu and kappa opioid agonists at the spinal cord level in the rat.
Laurido C; Hernandez A; Perez H
Int J Neurosci; 1996 Nov; 87(3-4):191-9. PubMed ID: 9003979
[TBL] [Abstract][Full Text] [Related]
16. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
Zhao M; Wang JY; Jia H; Tang JS
Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
[TBL] [Abstract][Full Text] [Related]
17. Ultralow dose fentanyl prevents development of chronic neuropathic pain in rats.
Wala EP; Holtman JR; Sloan PA
J Opioid Manag; 2013; 9(2):85-96. PubMed ID: 23709318
[TBL] [Abstract][Full Text] [Related]
18. Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Anesthesiology; 2000 Mar; 92(3):786-94. PubMed ID: 10719957
[TBL] [Abstract][Full Text] [Related]
19. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors.
Catheline G; Kayser V; Guilbaud G
Eur J Pharmacol; 1996 Nov; 315(2):135-43. PubMed ID: 8960876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]